Biological Psychiatry 2002: Vol 52 Index

16 Pages·2002·5.8 MB·English

Author Index to Volume 52
Akechi T. See Uchitomi Y Beardslee WR. See Hollon SD Bowley MP, Drevets WC, Ongiir D,
Alam D. See Janicak PG Beasley CL, Zhang ZJ, Patten I, Price JL. Low glial numbers in the
Alexopoulos GS. See Krishan KRR Reynolds GP. Selective deficits in amygdala in major depressive
Alexopoulos GS, Borson S, Cuthbert BN, prefrontal corticdal GABAergic disorder, 404
Devanand DP, Mulsant BH, Olin neurons in schizophrenia defined by Brady L. See Tamminga CA
JT, Oslin DW. Assessment of late the presence of calcium-binding Brecher M. See Geller W
life depression, 164 proteins, 708 Bregartner TA. See George TP
Alexopoulos GS, Buckwalter K, Olin J, Beedle D. See Janicak PG Breier A, Sutton VK, Feldman PD,
Martinez R, Wainscott C, Krishan Beers SR. See De Bellis MD Kadam DL, Ferchland I, Wright P,
KRR. Cormorbidity on late life Begleiter H. See Rangaswamy M Friedman JH. Olanzapine in the
depression: an opportunity for Belanoff JK, Rothschild AJ, Cassidy F, treatment of dopamimetic-induced
research on mechanisms and DeBattista C, Baulieu E-E, Schold psychosis in patients with
treatment, 543 C, Schatzberg AF. An open label Parkinson’s disease, 438
Alloy LB. See Davidson RJ trial of C-1073 (mifepristone) for Brent L, Koban T, Ramirez S. Abnormal,
Altshuler LL. See McElroy SL; Suri R psychotic major depression, 386 abusive, and stress-related
Amaral DG. See Davidson RJ Bell CC. See Hollon SD behaviors in baboon mothers, 1047
Amo C. See Fernadez A Bellodi L. See Cavallaro R Brody S. High-dose ascorbic acid
Amodio S. See Cavallaro R Benson BE. See Kimbrell TA increases intercourse frequency and
Anderson GM. See K6hnke MD Bergman J. See Laakso A improves mood: a randomized
Anderson TS. See Geraci M Bernal G. See Hollon SD controlled clinical trial, 371
Andreasen NC. See Chemerinski E; Biederman J. See Costello EJ Brooks WM. See Villarreal G
Corson PW Bilder RM. See Hoptman MJ Bruce ML. See Wells KB
Araj H. See Matsushita S; Merikangas Bilder RM, Volavka J, Czobor P, Bruce ML. Psychosocial risk factors for
KR Malhotra AK, Kennedy JL, Ni X, depressive disorders in late life, 175
Archibald SL. See Fennema-Notestine C Goldman RS, Hoptman MJ, Bucan M. See Nestler EJ
Arciniegas DB. See Rojas DC Sheitman B, Lindenmayer J-P, Buchkremer G. See K6hnke MD
Arean PA, Cook BL. Psychotherapy and Citrome L, McEvoy JP, Kunz M, Buckwalter K. See Alexopoulos GS;
combined psychotherapy/ Chakos M, Cooper TB, Lieberman
Krishan KRR
pharmacotherapy for late life JA. Neurocognitive correlates of the
Burmeister M. See Merikangas KR
depression, 293 COMT Vall58Met polymorphism
Bush G. See Davidson RJ
Aschauer HN. See Bailer U in chronic schizophrenia, 701
Au TH. See Steingard RJ Birbaumer N. See Hermann C
Caine ED. See Conwell Y
Autio KA. See McElroy SL Birnbaum R. See Pascual-Leone A
Carlson JP. See Rojas DC
Avila MT. See Sherr JD Blakely RD. See Tamminga CA
Carney R. See Krishan KRR
Blangero J. See Merikangas KR
Carter CS. See Tamminga CA
Babich KS. See Charney DS Blaxton TA. See Sherr JD
Cassidy F. See Belanoff JK
Bailer U, Leisch F, Meszaros K, Lenzinger Blehar M. See Frank E
Cavallaro R, Galardi G, Cavallini MC,
E, Willinger U, Strobl R, Heiden A, Boas DA. See Strangman G
Henin M, Amodio S, Bellodi L,
Gebhardt C, Dége E, Fuchs K, Boksa P. See Flores C
Comi G. Obsessive compulsive
Sieghart W, Kasper S, Hornik K, Boksman K. See Lanius RA
disorder among idiopathic focal
Aschauer HN. Genome scan for Borson S. See Alexopoulos GS
susceptibility loci for schizophrenia Boshuisen ML, Ter Horst GJ, Paans dystonia patients: an
and bipolar disorder, 40 AMJ, Reinders AATS, den Boer epidemiological and family study,
Baker GB. See Mejia JM JA. rCBF differences between panic 356
Barlow DH. See Hollon SD disorder patients and control Cavallini MC. See Cavallaro R
Barnea-Goraly N. See Eliez S subjects during anticipatory anxiety Chakos M. See Bilder RM
Bauer LO. See Rangaswamy M and rest, 126 Chakravarti A. See Merikangas KR
Bauer MS. See Wells KB Bouton ME. Context, ambiguity, and Chang C-G. See Lyoo IK
Baulieu E-E. See Belanoff JK unlearning: sources of relapse after Charlson M, Peterson JC. Medical
Bawn SD. See Rojas DC behavioral extinction, 976 comorbidity and late life
© 2002 Society of Biological Psychiatry 0006-3223/02/$22.00
PIL SO0006-3223(02)01889-9
1198 BIOL PSYCHIATRY Author Index to Volume 52
2002;52:1197—1204
depression: what is known and repetitive transcranial magnetic Duman RS. See Nestler EJ
what are the unmet needs?, 226 stimulation: effects on stress Durham M. See Wells KB
Charney DS. See Gold PW; Pine DS; hormone levels and adult
Reynolds CF III hippocampal neurogenesis, 1057 Elbert T. See Fernaddez A
Charney DS, Babich KS. Foundation for Czobor P. See Bilder RM Eliez S, Barnea-Goraly N, Schmitt JE,
the NIMH strategic plan for mood Liu Y, Reiss AL. Increased basal
disorders research, 455 d’ Alfonso AAL. See van Honk J ganglia volumes in velo-cardio-
Chemerinski E, Nopoulos PC, Crespo- Davidson RJ, Lewis DA, Alloy LB, facial syndrome (deletion 22q11.2),
Facorro B, Andreasen NC, Amaral DG, Bush G, Cohen JD, 68
Magnotta V. Morphology of the Drevets WC, Farah MJ, Kagan J, Elliott A. See Sherr JD
ventral frontal cortex in McClelland JL, Nolen-Hoeksema S, Entsuah AR. See Stahl SM
schizophrenia: relationship with Peterson BS. Neural and behavioral Epel ES. See Stroud LR
social dysfunction, | substrates of mood and mood Erhardt A. See Czéh B
Cho E. See Essex MJ regulation, 478 Ervin FR. See Mejia JM
Chorlian DB. See Rangaswamy M Davis KL. See Tamminga CA Escalona R. See Villarreal G
Cintron CB. See Steingard RJ Davis M, Myers KM. The role of Escobar J. See Wells KB
Citrome L. See Bilder RM glutamate and gamma-aminobutyric Essex MJ, Klein MH, Cho E, Kalin NH.
Clarke GN. See Hollon SD acid in fear extinction: clinical Maternal stress beginning in
Cohen JD. See Davidson RJ implications for exposure therapy, infancy may sensitize children to
Cohen PD. See Krishan KRR 998 later stress exposure: effects
Comi G. See Cavallaro R De Bellis MD, Keshavan MS, Shifflett H, overview on cortisol and behavior,
Condren R. See Walsh M-T Iyengar S, Beers SR, Hall J, Moritz 776
Connor DF. See Steingard RJ G. Brain structures in pediatric Essock S. See Frank E
Constable RT. See Shaywitz BA maltreatment-related posttraumatic Evans D. See Krishan KRR
Conwell Y, Duberstein PR, Caine ED. stress disorder: a sociodemograph-
Risk factors for suicide in later life, ically matched study, 1066 Farah MJ. See Davidson RJ
193 de Haan EHF. See van Honk J Faraone SV. See Wilcox MA
Cook BL. See Arean PA de Kloet ER. See Rinne T Farchione TR, Moore GJ, Rosenberg DR.
Cooper KL. See Mostofsky SH DeBattista C. See Belanoff JK Proton magnetic resonance
Cooper TB. See Bilder RM DelBello MP. See L6pez-Larson MP spectroscopic imaging in pediatric
Copolov DL. See Yiicel M Delong M. See Krishan KRR major depression, 86
Corson PW, O'Leary DS, Miller DD, den Boer JA. See Boshuisen ML Fatemi SH, Halt AR, Stary JM, Kanodia
Andreasen NC. The effects of Denckla MB. See Mostofsky SH R, Schultz SC, Realmuto GR.
neuroleptic medications on basal Denicoff KD. See McElroy SL Glutamic acid decarboxylase 65 and
ganglia blood flow in Densmore M. See Lanius RA 67 kDa proteins are reduced in
schizophreniform disorders: a Depaulo JR Jr. See Merikangas KR autistic parietal and cerebellar
comparison between the DeRijk RH. See Rinne T cortices, 805
neuroleptic-naive and medicated Dettling AC, Feldon J, Pryce CR. Feingold A. See George TP
states, 855 Repeated parental deprivation in the Feldman PD. See Breier A
Costelio EJ, Pine DS, Hammen C, March infant common marmoset Feldon J. See Dettling AC; Leumann L
JS, Plotsky PM, Weissman MM, (Callithrix Jacchus, primates) and Fennema-Notestine C, Stein MB,
Biederman J, Goldsmith HH, analysis of its effects on early Kennedy CM, Archibald SL,
Kaufman J, Lewinsohn PM, development, 1037 Jernigan TL. Brain morphometry in
Hellander M, Hoagwood K, Koretz Devanand DP. See Alexopoulos GS female victims of intimate partner
DS, Nelson CA, Leckman JF. Devanand DP. Comorbid psychiatric violence with and without
Development and natural history of disorders in late life depression, posttraumatic stress disorder, 1089
mood disorders, 529 236 Ferchland I. See Breier A
Courchesne E. See Pierce K Dew MA. See Krishan KRR Fernandez A, Maestu F, Amo C, Gil P,
Crabbe JC Jr. See Merikangas KR Dinan T. See Walsh M-T Fehr T, Wienbruch C, Rockstroh B,
Crespo-Facorro B. See Chemerinski E Dingledine R. See Tamminga CA Elbert T, Ortiz T. Focal
Crowe SF. See Yiicel M Doge E. See Bailer U temporoparietal slow activity in
Cubells JF. See K6hnke MD Dowd SM. See Janicak PG Alzheimer’s disease revealed by
Cuthbert BN. See Alexopoulos GS Drayer RA. See Schulz R magnetoencephalography, 764
Czéh B, Welt T, Fischer AK, Erhardt A, Drevets WC. See Bowley MP; Davidson Fink M. See Kellner CH
Schmitt W, Miiller MB, Toschi N, RJ; Gold PW Fischer AK. See Czéh B
Fuchs E, Keck ME. Chronic Driscoll I. See Villarreal G Fletcher JM. See Klorman R; Shaywitz
psychosocial stress and concomitant Duberstein PR. See Conwell Y BA
Author Index to Volume 52 BIOL PSYCHIATRY
2002;52:1197—1204
Flor H. See Hermann C irradiated nonhuman primates: Hasegawa K. See Ono K
Flores C, Stewart J, Salmaso N, Zhang Y, implications for the Hauger RL. See Morgan CA III
Boksa P. Astrocytic basic fibroblast neurodevelopmental hypothesis of Hazlett G. See Morgan CA III
growth factor expression in schizophrenia, 716 Heiden A. See Bailer U
dopaminergic regions after perinatal George MS. See Kimbrell TA Hellander M. See Costello EJ
anoxia, 362 George TP, Vessicchio JC, Termine A, Hen R. See Nestler EJ
Foa ED, Franklin ME, Moser J. Context Bregartner TA, Feingold A, Henderson DC. See Tamminga CA
in the clinic: how well do Rounsaville BJ, Kosten TR. A Hendrick V. See Suri R
cognitive-behavioral therapies and placebo controlled trial of Henin M. See Cavallaro R
medications work in combination?, bupropion for smoking cessation in Hennen J. See Steingard RJ
987 schizophrenia, 53 Hermann C, Ziegler S, Birbaumer N, Flor
Ford D. See Wells KB Geraci M, Anderson TS, Slate-Cothren S, H. Psychopsychological and
Foulks E. See Merikangas KR Post RM, McCann UD.
subjective indicators of aversive
Franciosi LP. See Hollon SD Pentagastrin-induced sleep panic
Pavlovian conditioning in
Frank E, Rush AJ, Blehar M, Essock S, attacks: panic in the absence of
generalized social phobia, 328
Hargreaves W, Hogan M, Jarrett R, elevated baseline arousal, 1183
Herscovitch P. See Kimbrell TA
Johnson RL, Katon WJ, Lavori P, Gershenfeld HK. See Nestler EJ
Herva A. See Timonen M
McNulty JP, Niederehe G, Ryan N, Gil P. See Fernadez A
Hietala J. See Laakso A
Stuart G, Thomas SB, Tollefson Gispen-de Wied CC. See Oranje B
Higuchi S. See Matsushita S
GD, Vitiello B. Skating to where Glenthoj BY. See Mackeprang T
Hillmann A. See Walsh M-T
the puck is going to be: a plan for Goekoop JG. See Rinne T
Hoagwood K. See Costello EJ; Wells KB
clinical trials and translation Goff DC. See Pascual-Leone A
Hogan M. See Frank E
research in mood disorders, 631 Gold PW, Drevets WC, Charney DS.
Holahan JM. See Klorman R
Frank GK, Kaye WH, Meltzer CC, Price New insights into the role of
Hollon SD, Munoz RF, Barlow DH,
JC, Greer P, McConaha C, Skovira cortisol and the glucocorticoid
Beardslee WR, Bell CC, Bernal G,
K. Reduced 5-HT2A receptor receptor in severe depression, 381
Clarke GN, Franciosi LP, Kazdin
binding after recovery from Goldman RS. See Bilder RM
AE, Kohn L, Linehan MM,
anorexia nervosa, 896 Goldman-Rakic PS. See Gelowitz DL
Markowitz JC, Miklowitz DJ,
Franke L, Uebelhack R, Miiller- Goldsmith HH. See Costello EJ
Persons JB, Niederehe G, Sommers
Oerlinghausen B. Low CSF 5- Golier JA. See Yehuda R
D. Psychosocial intervention
HIAA level in high-lethality suicide Gonzalez J. See Wells KB
development for the prevention and
attempers: fact or artifact?, Gordon C. See Krishan KRR
treatment of depression: promoting
375-corr Gordon E. See Loughland CM
innovation and increasing access,
Franklin ME. See Foa ED Gore JC. See Shaywitz BA
610
Fredrikson M. See Tillfors M Gorman JM. See Kent JM; Khan A;
Holsboer F. See Modell S
Freimer NB. See Merikangas KR Tamminga CA
Hoptman MJ. See Bilder RM
Friedman JH. See Breier A Gould E. See Nestler EJ
Hoptman MJ, Volavka J, Johnson G,
Frye MA. See McElroy SL Greer P. See Frank GK
Weiss E, Bilder RM, Lim KO.
Fuchs E. See Czéh B Griego JA. See Villarreal G
Frontal white matter microstructure,
Fuchs K. See Bailer U Grigoriadis DE. See Tamminga CA
aggression, and impulsivity in men
Fulbright RK. See Shaywitz BA Grillon C. Startle reactivity and anxiety
with schizophrenia: a preliminary
Furmark T. See Tillfors M disorders: aversive conditioning,
study, 9
context, and neurobiology, 958
Hornik K. See Bailer U
Gaertner I. See K6hnke MD Grossman R. See Yehuda R
Horwitz SM. See Wells KB
Galardi G. See Cavallaro R Gupta M. See Lanius RA
Hostetter A. See Suri R
Gati JS. See Lanius RA
Hoyt G. See Morgan CA III
Gebhardt C. See Bailer U Haaparanta M. See Laakso A
Husain M. See Kellner CH
Gehr T. See Fernadez A Hall J. See De Bellis MD
Geller W, Smith M, Winter H, Brecher Halligan SL. See Yehuda R
M. Comment on “Possible Halt AR. See Fatemi SH Inagaki M. See Uchitomi Y
association of QTc interval Hamilton DA. See Villarreal G Innes-Brown H. See Michie PT
prolongation with co-administration Hammen C. See Costello EJ Innis RB. See Tamminga CA
of quetiapine and lovastatin,” Han H. See Klimek V Ising M. See Modell S
915-corr Han MH. See Lyoo IK Iwatsubo T. See Matsushita S
Gelowitz DL, Rakic P, Goldman-Rakic Hargreaves W. See Frank E Iyengar S. See De Bellis MD
PS, Selemon LD. Craniofacial Hart BL. See Villarreal G
dysmorphogenesis in fetally Harvey PD. See Mitropoulou V Jablensky AV. See Michie PT
1200 BIOL PSYCHIATRY Author Index to Volume 52
2002;52:1197—1204
Janicak PG, Viana M, Dowd SM, Martis Khan A, Khan SR, Leventhal RM, Cohen PD, Evans D, Kaufmann
B, Beedle D, Alam D, Krasuski J, Krishnan RR, Gorman JM. An PG, Olin J, Otey E, Wainscott C.
Strong MJ, Sharma R, Rosen C. application of the revised Comorbidity of depression with
Comment on “Repetitive CONSORT standards to FDA other medical diseases in the
transcranial magnetic stimulation summary reports of recently elderly, 559
versus electroconvulsive therapy for approved antidepressants and Krishnan KRR. Biological risk factors in
major depression: preliminary antipsychotics, 62 late life depression, 185
results of a randomized trial,” Khan SR. See Khan A Krishnan RR. See Khan A
1032-—corr (reply) Killen J. See Tamminga CA Kristiansen KT. See Mackeprang T
Jarrett R. See Frank E Kimbrell TA, Ketter TA, George MS, Kugaya A. See Uchitomi Y
Jayaraman A. See Yeragani VK Little JT, Benson BE, Willis MW, Kunz M. See Bilder RM
Jentsch JD, Olausson P, Nestler EJ, Herscovitch P, Post RM. Comment Kuperman S. See Rangaswamy M
Taylor JR. Stimulation of protein on “Regional cerebral glucose Kupka RW. See McElroy SL
kinase A activity in the rat utilization in patients with a range Kwon JS. See Lyoo IK
amygdala enhances reward-related of severities of unipolar
learning, 111 depression,” 1031—corr (reply) Laakso A, Vilkman H, Bergman J,
Jernigan TL. See Fennema-Notestine C Klein MH. See Essex MJ Haaparanta M, Solin O, Syvalahti
Johnson G. See Hoptman MJ Klimek V, Schenck JE, Han H, E, Salokangas RKR, Hietala J. Sex
Johnson RL. See Frank E Stockmeier CA, Ordway GA. differences in striatal presynaptic
Jokelainen J. See Timonen M Dopaminergic abnormalities in dopamine synthesis capacity in
Jones KA. See Rangaswamy M amygdaloid nuclei in major healthy subjects, 759
Jurjus G. See Miguel-Hidalgo JJ depression: a postmortem study, Lanius RA, Williamson PC, Boksman K,
740 Densmore M, Gupta M, Neufeld
Kadam DL. See Breier A Klorman R, Thatcher JE, Shaywitz SE, RWJ, Gati JS, Menon RS. Brain
Kagan J. See Davidson RJ Fletcher JM, Marchione KE, activation during script-driven
Kagaya A. See Uchitomi Y Holahan JM, Stuebing KK, imagery induced dissociative
Kahn RS. See Oranje B Shaywitz BA. Effects of event responses in PTSD: a functional
Kalin NH. See Essex MJ probability and sequence on magnetic resonance imaging
Kanodia R. See Fatemi SH children with investigation, 305
Kasper S. See Bailer U attention-deficit/hyperactivity, Lauer CJ. See Modell S
Kates WR. See Mostofsky SH reading, and math disorder, 795 Laughren TP. See Tamminga CA
Katon WJ. See Frank E Koban T. See Brent L Lavori P. See Frank E
Kaufman J. See Costello EJ Kodituwakku PW. See Villarreal G Lawson W. See Wells KB
Kaufmann PG. See Krishan KRR Koester S. See Nestler EJ Leckman JF. See Costello EJ
Kaufmann WE. See Mostofsky SH Kohn L. See Hollon SD Lederhendler I. See Nestler EJ
Kaye WH. See Frank GK Kohnke AM. See K6hnke MD Lee L. See Ni X
Kazdin AE. See Hollon SD K6hnke MD, Zabetian CP, Anderson Lee SI. See Lyoo IK
Keck ME. See Czéh B GM, Kolb W, Gaertner I, Lee SJ. See Lyoo IK
Keck PE Jr. See McElroy SL Buchkremer G, Vonthein R, Schick Leisch F. See Bailer U
Kellner CH, Husain M, Petrides G, Fink S, Lutz U, Kéhnke AM, Cubells JF. Lenox M. See Steingard RJ
M, Rummans T. Comment on A genotype-controlled analysis of Lenzinger E. See Bailer U
“Repetitive transcranial magnetic plasma dopamine b-hydroxylase in Leumann L, Feldon J, Vollenweider FX,
stimulation versus electroconvulsive healthy and alcoholic subjects: Ludewig K. Effects of typical and
therapy for major depression: evidence for alcohol-related atypical antipsychotics on prepulse
preliminary results of a randomized differences in noradrenergic inhibition and latent inhibition in
trial,” 1032—corr function, 1151 chronic schizophrenia, 729
Kennedy CM. See Fennema-Notestine C; Kolb W. See K6hnke MD Leventhal RM. See Khan A
Stein MB Koretz DS. See Costello EJ; Merikangas Lewinsohn PM. See Costello EJ
Kennedy JL. See Bilder RM; Ni X KR Lewis DA. See Davidson RJ
Kenny D. See Walsh M-T Kosten TR. See George TP Lewis L. See Wells KB
Kent JM, Mathew SJ, Gorman JM. Kraemer H. See Krishan KRR Lichtenstein W. See Merikangas KR
Molecular targets in the treatment Krasuski J. See Janicak PG Lieberman JA. See Bilder RM
of anxiety, 1008 Krishan KRR. See Alexopoulos GS Lim KO. See Hoptman MJ
Keshavan MS. See De Bellis MD; Yao Krishan KRR, Delong M, Kraemer H, Lindenmayer J-P. See Bilder RM
JK Carney R, Spiegel D, Gordon C, Linehan MM. See Hollon SD
Kessels RPC. See van Honk J McDonald W, Dew MA, Little JT. See Kimbrell TA
Ketter TA. See Kimbrell TA Alexopoulos G, Buckwalter K, Liu Y. See Eliez S
Author Index to Volume 52 BIOL PSYCHIATRY 1201
2002;52:1197-1204
Loganovsky K. Comment on Maruff P. See Yiicel M Rajkowska G. Glia pathology in the
“Abnormalities of thalamic volume Maruyama M. See Matsushita S prefrontal cortex in alcohol
and shape detected in fetally Mathew SJ. See Kent JM dependence with and without
irradiated rhesus monkeys with high Matsui T. See Matsushita S depressive symptoms, 1121
dimensional brain mapping,” Matsuoka Y. See Uchitomi Y Miklowitz DJ. See Hollon SD
91 1—corr Matsushita S, Arai H, Okamura N, Miller DD. See Corson PW
L6épez-Larson MP, DelBello MP, Ohmori T, Takasugi K, Matsui T, Mineka S, Ohman A. Phobias and
Zimmerman ME, Schwiers ML, Maruyama M, Iwatsubo T, Higuchi preparedness: the selective,
Strakowski SM. Regional prefrontal S. Clinical and biomarker automatic, and encapsulated nature
gray and white matter abnormalities investigation of a patient with a of fear, 927
in bipolar disorder, 93 novel presenilin-1 mutation Miranda J. See Wells KB
Loughland CM, Williams LM, Gordon E. (A431V) in the mild cognitive Mitropoulou V, Harvey PD, Maldari LA,
Schizophrenia and affective impairment stage of Alzheimer’s Moriarty PJ, New AS, Silverman
disorder show different visual disease, 907 JM, Siever LJ. Neuropsychological
scanning behavior for faces: a trait McCann UD. See Geraci M performance in schizotypal
versus state-based distinction?, 338 McClelland JL. See Davidson RJ personality disorder: evidence
Ludewig K. See Leumann L McConaha C. See Frank GK regarding diagnostic specificity,
Lutz U. See K6hnke MD McDonald W. See Krishan KRR 1175
Lyketsos CG, Olin J. Depression in McDonald WM. See Tamminga CA Modell S, Ising M, Holsboer F, Lauer CJ.
Alzheimer’s disease: overview and McElroy SL, Suppes T, Keck PE Jr, The Munich vulnerability study on
treatment, 243 Denicoff KD, Nolen WA, Altshuler affective disorders: stability of
Lyon GR. See Shaywitz BA LL, Rush AJ, Kupka RW, Frye polysomnographic findings over
Lyoo IK, Kwon JS, Lee SJ, Han MH, MA, Autio KA, Post RM. Early time, 430
Chang C-G, Seo CS, Lee SI, physical and sexual abuse Moldin SO. See Merikangas KR
Renshaw PF. Decrease in genu of associated with an adverse course Moore GJ. See Farchione TR
the corpus callosum in medication- of bipolar illness, 843—corr (reply) Morgan CA III, Rasmusson AM, Wang
naive, early-onset dysthymia and McEvoy JP. See Bilder RM S, Hoyt G, Hauger RL, Hazlett G.
depressive personality disorder, McGuire T. See Wells KB Neuropeptide-Y, cortisol, and
1134 McNally RJ. Anxiety sensitivity and subjective distress in humans
panic disorder, 938 exposed to acute stress: replication
Macciardi FM. See Ni X McNulty JP. See Frank E and extension of previous report,
Mackeprang T, Kristiansen KT, Glenthoj Meaney MJ. See Nestler EJ 136
BY. Effects of antipsychotics on Mejia JM, Ervin FR, Baker GB, Palmour Moriarty PJ. See Mitropoulou V
prepulse inhibition of the startle RM. Monoamine oxidase inhibition Moritz G. See De Bellis MD
response in drug-naive during brain development induces Moser J. See Foa ED
schizophrenic patients, 863 pathological aggressive behavior in Mostofsky SH, Cooper KL, Kates WR,
Maestui F. See Fernadez A mice, 811 Denckla MB, Kaufmann WE.
Magnotta V. See Chemerinski E Meltzer CC. See Frank GK Smaller prefrontal and premotor
Maldari LA. See Mitropoulou V Mencl E. See Shaywitz BA volumes in boys with attention-
Malhotra AK. See Bilder RM Menon RS. See Lanius RA deficit/hyperactivity disorder, 785
Manji HK. See Nestler EJ; Payne JL Merikangas KR, Chakravarti A, Moldin Miiller MB. See Czéh B
Mann JJ, Placidi GPA. Low CSF 5-HIAA SO, Araj H, Blangero J, Burmeister Mulsant BH. See Alexopoulos GS;
level in high-lethality suicide M, Crabbe JC Jr, Depaulo JR Jr, Whyte EM
attempers: fact or artifact?, 375- Foulks E, Freimer NB, Koretz DS, Mundo E. See Ni X
corr (reply) Lichtenstein W, Mignot E, Reiss Munoz RF. See Hollon SD
Manoach DS. See Pascual-Leone A AL, Risch NJ, Takahashi JS. Future Murphy GM Jr. See Tamminga CA
Marazziti D. A further support to the of genetics of mood disorders Myers C. See Sherr JD
hypothesis of a link between research, 457 Myers KM. See Davis M
serotonin, autism, and the Meszaros K. See Bailer U
cerebellum, 143—corr Michie PT, Innes-Brown H, Todd J, Naiki H. See Ono K
March JS. See Costello EJ Jablensky AV. Duration mismatch Nakano T. See Uchitomi Y
Marchione KE. See Klorman R; Shaywitz negativity in biological relatives of Nelson CA. See Costello EJ
BA patients with schizophrenia Nemeroff CB. See Tamminga CA
Markowitz JC. See Hollon SD spectrum disorders, 749 Nestler EJ. See Jentsch JD
Marteinsdottir I. See Tillfors M Mignot E. See Merikangas KR Nestler EJ, Gould E, Manji H, Bucan M,
Martinez R. See Alexopoulos GS Miguel-Hidalgo JJ, Wei J, Overholser AJ, Duman RS, Gershenfeld HK, Hen
Martis B. See Janicak PG Jurjus G, Stockmeier CA, R, Koester S, Lederhendler I,
1202 BIOL PSYCHIATRY Author Index to Volume 52
2002;52:1197—1204
Meaney MJ, Robbins T, Winsky L, does the robust upregulation of Rasianen P. See Timonen M
Zalcman §S. Preclinical models: noradrenergically regulated Rasmusson AM. See Morgan CA III
status of basic research in plasticity genes underlie the rapid Realmuto GR. See Fatemi SH
depression, 503 antidepressant effects of sleep Reddy RD. See Yao JK
Neufeld RWJ. See Lanius RA deprivation?, 921 Reich T. See Rangaswamy M
New AS. See Mitropoulou V Peltola O. See Timonen M Reinders AATS. See Boshuisen ML
Ni X. See Bilder RM Persons JB. See Hollon SD Reiss AL. See Eliez S; Merikangas KR
Ni X, Trakalo JM, Mundo E, Macciardi Pesce V. See Yeragani VK Reite ML. See Rojas DC
FM, Parikh S, Lee L, Kennedy JL. Peterson BS. See Davidson RJ Renshaw PF. See Lyoo IK; Steingard RJ
Linkage disequilibrium between Peterson JC. See Charlson M Reynolds CF III, Charney DS. Unmet
dopamine D1 receptor gene Petrides G. See Kellner CH needs in the diagnosis and
(DRD1) and bipolar disorder, 1144 Petropoulos H. See Villarreal G treatment of mood disorders in later
Niederehe G. See Frank E; Hollon SD Pettegrew JW. See Yao JK life, 145
Nolen WA. See McElroy SL Pierce K, Courchesne E. A further Reynolds GP. See Beasley CL
Nolen-Hoeksema S. See Davidson RJ support to the hypothesis of a link Reynolds MM. Mood disorders in late
Nopoulos PC. See Chemerinski E between serotonin, autism, and the life: a patient’s perspective, 148
cerebellum, 143-—corr (reply) Rinne T, de Kloet ER, Wouters L,
O’Connor SJ. See Rangaswamy M Pincus H. See Wells KB Goekoop JG, DeRijk RH, van den
Ohman A. See Mineka S Pine DS. See Costello EJ Brink W. Hyperresponsiveness of
Ohmori T. See Matsushita S Pine DS, Charney DS. Children, stress, hypothalamic-pituitary-adrenal axis
Okamura N. See Matsushita S and sensitization: an integration of to combined dexamethasone/
Olausson P. See Jentsch JD basic and clinical research on corticotropin-releasing hormone
O’Leary DS. See Corson PW emotion?, 773 challenge in female borderline
Olin J. See Alexopoulos GS; Krishan Pizzagalli DA, Nitschke JB, Oakes TR, personality disorder subjects with a
KRR; Lyketsos CG Hendrick AM, Horras KA, Larson history of sustained childhood
Olin JT. See Alexopoulos GS CL, Abercrombie HC, Schaefer abuse, 1102
Ongiir D. See Bowley MP SM, Koger JV, Benca RM, Risch NJ. See Merikangas KR
Ono K, Hasegawa K, Yamada M, Naiki Pascual-Marqui RD, Davidson RJ. Robbins T. See Nestler EJ
H. Nicotine breaks down preformed Brain electrical tomography in Rockstroh B. See Fernadez A
Alzheimer’s b-amyloid fibrils in depression: the importance of Rohrbaugh J. See Rangaswamy M
vitro, 880 symptom severity, anxiety, and Rojas DC, Bawn SD, Carlson JP,
Oranje B, Gispen-de Wied CC, Verbaten melancholic features, 73 Arciniegas DB, Teale PD, Reite
MN, Kahn RS. Modulating sensory Placidi GPA. See Mann JJ ML. Alterations in tonotopy and
gating in healthy volunteers: the Plotsky PM. See Costello EJ auditory cerebral asymmetry in
effects of ketamine and haloperidol, Porjesz B. See Rangaswamy M schizophrenia, 32
887 Post RM. See Geraci M; Kimbrell TA; Rollman BL. See Schulz R
Ordway GA. See Klimek V McElroy SL Roose S. See Yeragani VK
Ortiz T. See Fernadez A Price JC. See Frank GK Rosen C. See Janicak PG
Oslin DW. See Alexopoulos GS Price JL. See Bowley MP Rosenberg DR. See Farchione TR
Otey E. See Krishan KRR Pryce CR. See Dettling AC Rothman DL. See Shen J
Otto MW. Learning and “unlearning” Pugh KR. See Shaywitz BA Rothschild AJ. See Belanoff JK
fears: preparedness, neural Rounsaville BJ. See George TP
pathways, and patients, 917—ed Quiroz JA. See Payne JL Rowland LM. See Villarreal G
Overholser AJ. See Miguel-Hidalgo JJ Rudolph RL. See Stahl SM
Rajkowska G. See Miguel-Hidalgo JJ Rudorfer MV. See Tamminga CA
Paans AMJ. See Boshuisen ML Rakic P. See Gelowitz DL Rummans T. See Kellner CH
Palmour RM. See Mejia JM Ramirez S. See Brent L Rush AJ. See Frank E; McElroy SL
Pantelis C. See Yiicel M Rangaswamy M, Porjesz B, Chorlian DB, Ryan M. See Walsh M-T
Parikh S. See Ni X Wang K, Jones KA, Bauer LO, Ryan N. See Frank E
Pascual-Leone A, Manoach DS, Rohréaugh J, O’Connor SJ,
Birnbaum R, Goff DC. Motor Kuperman S, Reich T, Begleiter H. Salmaso N. See Flores C
cortical excitability in Beta power in the EEG of Salokangas RKR. See Laakso A
schizophrenia, 24 alcoholics, 831 Salovey P. See Stroud LR
Patten I. See Beasley CL Rapee RM. The development and Salzman C, Wong E, Wright BC. Drug
Paul SM. See Tamminga CA modification of temperamental risk and ECT treatment of depression in
Payne JL, Quiroz JA, Zarate CA Jr, for anxiety disorders: prevention of the elderly, 1996-2001: a literature
Manji HK. Timing is everything: a lifetime of anxiety?, 947 review, 265
Author Index to Volume 52 BIOL PSYCHIATRY 1203
2002;52:1197-—1204
Sausville E. See Tamminga CA Smith M. See Geller W Dingledine R, Gorman JM,
Savage GR. See Yiicel M Smith WA. See Wells KB Grigoriadis DE, Henderson DC,
Schatzberg AF. See Belanoff JK; Solin O. See Laakso A Innis RB, Killen J, Laughren TP,
Tamminga CA Sommers D. See Hollon SD McDonald WM, Murphy GM Jr,
Scheffler R. See Wells KB Spiegel D. See Krishan KRR Paul SM, Rudorfer MV, Sausville
Schenck JE. See Klimek V Stahl SM, Entsuah AR, Rudolph RL. E, Schatzberg AF, Scolnick EM,
Schick S. See K6hnke MD Comparative efficacy between Suppes T. Developing novel
Schmitt JE. See Eliez S venlafaxine and SSRIs: a pooled treatments for mood disorders:
Schmitt W. See Czéh B analysis of patients with depression, accelerating discovery, 589
Schold C. See Belanoff JK 1166 Taylor JR. See Jentsch JD
Schultz SC. See Fatemi SH Stanley JA. See Yao JK Teale PD. See Rojas DC
Schulz R, Drayer RA, Rollman BL. Stary JM. See Fatemi SH
Ter Horst GJ. See Boshuisen ML
Depression as a risk factor for non- Stein MB. See Fennema-Notestine C
Termine A. See George TP
suicide mortality in the elderly, 205 Stein MB, Kennedy CM, Twamley EW.
Thaker GK. See Sherr JD
Schutter DJLG. See van Honk J Neuropsychological function in
Thakore JH. See Walsh M-T
Schwenk TL. Diagnosis of late life female victims of intimate partner
Thatcher JE. See Klorman R
depression: the view from primary violence with and without
Thomas SB. See Frank E
care, 157 posttraumatic stress disorder, 1079
Tillfors M, Furmark T, Marteinsdottir I,
Schwiers ML. See L6pez-Larson MP Steingard RJ, Renshaw PF, Hennen J,
Fredrikson M. Cerebral blood flow
Scolnick EM. See Tamminga CA Lenox M, Cintron CB, Young AD,
during anticipation of public
Scolnick EM. Discovery and development Connor DF, Au TH, Yurgelun-Todd
speaking in social phobia: a PET
of antidepressants: a perspective DA. Smaller frontal lobe white
study, 1113
from a pharmaceutical discovery matter volumes in depressed
Timonen M, Jokelainen J, Silvennoinen-
company, 154—comm adolescents, 413
Kassinen S, Herva A, Zitting P, Xu
Selemon LD. See Gelowitz DL Stewart J. See Flores C
B, Peltola O, Rasianen P.
Seo CS. See Lyoo IK Stockmeier CA. See Klimek V; Miguel-
Association between skin test
Sharma R. See Janicak PG Hidalgo JJ
diagnosed atopy and professionally
Shaywitz BA. See Klorman R Stowe ZN. See Suri R
diagnosed depression: a Northern
Shaywitz BA, Shaywitz SE, Pugh KR, Strakowski SM. See L6pez-Larson MP
Finland 1966 birth cohort study,
Mencl E, Fulbright RK, Skudlarski Strangman G, Boas DA, Sutton JP. Non-
349
P, Constable RT, Marchione KE, invasive neuroimaging using near-
Todd J. See Michie PT
Fletcher JM, Lyon GR, Gore JC. infrared light, 679
Tollefson GD. See Frank E
Disruption of posterior brain Strobl R. See Bailer U
Torrey EF. Early physical and sexual
systems for reading in children with Strong MJ. See Janicak PG
abuse associated with an adverse
developmental dyslexia, 101 Stroud LR, Salovey P, Epel ES. Sex
course of bipolar illness, 843—corr
Shaywitz SE. See Klorman R; Shaywitz differences in stress responses:
Toschi N. See Czéh B
BA social rejection versus achievement
Trakalo JM. See Ni X
Sheitman B. See Bilder RM stress, 318
Tsuang MT. See Wilcox MA
Shen J, Rothman DL. Magnetic resonance Stuart G. See Frank E
Twamley EW. See Stein MB
spectroscopic approaches to Stuart GW. See Yiicel M
studying neuronal: glial Stuebing KK. See Klorman R
interactions, 694 Su J. See Wilcox MA Uchitomi Y, Kugaya A, Akechi T,
Sherr JD, Myers C, Avila MT, Elliott A, Suppes T. See McElroy SL; Tamminga Nakano T, Inagaki M, Matsuoka Y,
Blaxton TA, Thaker GK. The CA Kagaya A, Yamawaki S. Lack of
effects of nicotine on specific eye Suri R, Stowe ZN, Hendrick V, Hostetter association between suicidal
tracking measures in schizophrenia, A, Widawski M, Altshuler LL. ideation and enhanced platelet 5-
721 Estimates of nursing infant daily HT2A receptor-mediated calcium
Shifflett H. See De Bellis MD dose of fluoxetine through breast mobilization in cancer patients with
Sieghart W. See Bailer U milk, 446 depression, 1159
Siever LJ. See Mitropoulou V Sutton JP. See Strangman G Uniitzer J. See Wells KB
Silvennoinen-Kassinen S. See Timonen Sutton VK. See Breier A
M Syvalahti E. See Laakso A van den Brink W. See Rinne T
Silverman JM. See Mitropoulou V Van Eerdewegh P. See Wilcox MA
Skovira K. See Frank GK Takahashi JS. See Merikangas KR van Honk J, Schutter DJLG, d’ Alfonso
Skudlarski P. See Shaywitz BA Takasugi K. See Matsushita S AAL, Kessels RPC, de Haan EHF.
Slate-Cothren S. See Geraci M Tamminga CA, Nemeroff CB, Blakely 1 Hz rT™S over the right prefrontal
Smith DJ. See Yiicel M RD, Brady L, Carter CS, Davis KL, cortex reduces vigilant attention to
1204 BIOL PSYCHIATRY Author Index to Volume 52
2002;52:1197-—1204
unmasked but not to masked fearful Gonzalez J, Hoagwood K, Horwitz polyunsaturated fatty acid content
faces, 312 SM, Lawson W, Lewis L, McGuire and in vivo membrane phospholipid
Velakoulis D. See Yiicel M T, Pincus H, Scheffler R, Smith metabolites, 823
Verbaten MN. See Oranje B WA, Uniitzer J. Overcoming Yehuda R, Halligan SL, Grossman R,
Vessicchio JC. See George TP barriers to reducing the burden of Golier JA, Wong C. The cortisol
Viana M. See Janicak PG affective disorders, 655 and glucocorticoid receptor
Videbech P. Comment on “Regional Welt T. See Czéh B response to low dose
cerebral glucose utilization in Whyte EM, Mulsant BH. Post stroke dexamethasone administration in
patients with a range of severities depression: epidemiology, aging combat veterans and
of unipolar depression,” 1031—corr pathophysiology, and biological Holocaust survivors with and
Vilkman H. See Laakso A treatment, 253 without posttraumatic stress
Villarreal G, Hamilton DA, Petropoulos Widawski M. See Suri R disorder, 393
H, Driscoll I, Rowland LM, Griego Wienbruch C. See Fernadez A Yeragani VK, Pesce V, Jayaraman A,
JA, Kodituwakku PW, Hart BL, Wilcox MA, Faraone SV, Su J, Van Roose S. Major depression with
Escalona R, Brooks WM. Reduced Eerdewegh P, Tsuang MT. Genome ischemic heart disease: effects of
hippocampal volume and total scan of three quantitative traits in paroxetine and nortriptyline on
white matter volume in schizophrenia pedigrees, 847 long-term heart rate variability
posttraumatic stress disorder, 119 Williams LM. See Loughland CM measures, 418
Vitiello B. See Frank E Williamson PC. See Lanius RA Young AD. See Steingard RJ
Volavka J. See Bilder RM; Hoptman MJ Willinger U. See Bailer U Yiicel M, Stuart GW, Maruff P, Wood
Vollenweider FX. See Leumann L Willis MW. See Kimbrell TA SJ, Savage GR, Smith DJ, Crowe
Vonthein R. See KO6hnke MD Winsky L. See Nestler EJ SF, Copolov DL, Velakoulis D,
Winter H. See Geller W Pantelis C. Paracingulate
Wainscott C. See Alexopoulos GS; Wong C. See Yehuda R morphologic differences in males
Krishan KRR Wong E. See Salzman C with established schizophrenia: a
Walsh M-T, Ryan M, Hillmann A, Wood SJ. See Yiicel M magnetic resonance imaging
Condren R, Kenny D, Dinan T, Wouters L. See Rinne T morphometric study, 15
Thakore JH. Elevated expression of Wright BC. See Salzman C Yurgelun-Todd DA. See Steingard RJ
integrin allbbIIla in drug-naive, first- Wright P. See Breier A
episode schizophrenic patients, 874 Zabetian CP. See K6hnke MD
Wang K. See Rangaswamy M Xu B. See Timonen M Zalcman S. See Nestler EJ
Wang S. See Morgan CA III Zarate CA Jr. See Payne JL
Wei J. See Miguel-Hidalgo JJ Yamada M. See Ono K Zhang Y. See Flores C
Weiss E. See Hoptman MJ Yamawaki S. See Uchitomi Y Zhang ZJ. See Beasley CL
Weissman MM. See Costello EJ Yao JK, Stanley JA, Reddy RD, Ziegler S. See Hermann C
Wells KB, Miranda J, Bauer MS, Bruce Keshavan MS, Pettegrew JW. Zimmerman ME. See Lépez-Larson MP
ML, Durham M, Escobar J, Ford D, Correlations between peripheral Zitting P. See Timonen M
Subject Index to Volume 52
Abuse monoamine oxidase inhibition during brain development
bipolar disorder and, 843—corr induces pathological aggression in mice, 811
childhood parental care deprivation effects on infant, 1037
borderline personality disorder secondary to, 1102 psychiatric disturbances during pregnancy and postpartum
posttraumatic stress disorder secondary to, 1066 period, 1047
maternal, 1047 startle reactivity and anxiety disorders, 958
sexual, 843—corr thalamic volume and shape abnormalities in rhesus
Achievement-oriented stress, 318 monkeys detected with high dimensional brain mapping,
Adolescents 911-—corr
depression in, frontal lobe gray and white matter volume Anorexia nervosa
reductions associated with, 413 serotonin 2A receptor binding reduction after recovery
Affective disorders from, 896
burden of, 655 Anoxia
polysomnographic studies, 430 dopaminergic regions affected by, 362
Sleep studies, 430 ventral tegmental area basic fibroblast growth factor
visual scanpath findings, 338 immunoreactivity effects, 362
Aggression Anticipatory anxiety
monoamine oxidase inhibition during brain development as in panic disorder
inducer of, 811 regional cerebral blood flow findings associated with,
schizophrenia 126
white matter microstructure alterations and, 9 in social phobia
Alcoholism regional cerebral blood flow findings associated with,
electroencephalogram beta power in, 831 1113
excitation—inhibition imbalance in, 831 Antidepressants
glial density and size reductions associated with, 1121 development of, 154-—comm
late-life depression and, 236 discovery of, 154-—comm
noradrenergic function differences, 1151 FDA summary reports of, 62
norepinephrine mediation, 1151 selective serotonin reuptake inhibitors, 1166
plasma dopamine B-hydroxylase activity in, 1151 sleep deprivation effects, 921
Alzheimer’s disease Antipsychotics
B-amyloid fibrils FDA summary reports of, 62
nicotine effects on, 880 latent inhibition effects, 729
cognitive impairment in, 907 prepulse inhibition effects, 729, 863
depression in, 242 sensory gating effects, 887
focal temporoparietal slow activity revealed by Anxiety
magnetoencephalography, 764 depression and
presenilin-1 mutation in, 907 description of, 73
Amygdala. See also Brain late-life, 236
dopaminergic abnormalities panic disorder-related, regional cerebral blood flow findings
in major depression, 740 associated with, 126
glia repetitive transcranial magnetic stimulation over prefrontal
in major depression, 404 cortex effects, 312
panic disorder-related differences in regional cerebral blood treatment of
flow, 126 cognitive-behavioral therapy, 917—ed
protein kinase A stimulation in molecular targets in, 1008
effects on reward-related learning in rats, 111 Anxiety disorders
8-Amyloid fibrils behavioral extinction, relapse after, 976
nicotine effects on, in Alzheimer’s disease, 880 prevention of, 945
Animal studies risk modification for, 945
craniofacial dysmorphogenesis in schizophrenia, 716 Anxiety sensitivity, 938
depression research, 502 Ascorbic acid
© 2002 Society of Biological Psychiatry 0006-3223/02/$22.00
PII S0006-3223(02)01890-5
1206 BIOL PSYCHIATRY Subject Index to Volume 52
2002;52:1205—1212
mood improvements using, 371 in schizophrenia-related social dysfunction, 1
sexual intercourse frequency and, 371 white matter. See White matter
Atopic diseases Breast milk
depression risks and, 349 fluoxetine levels in, 446
Attention-deficit/hyperactivity disorder Brief dynamic therapy
event probability and sequence effects, 795 late-life depression treated using, 293
frontal lobe gray and white matter volumes in, 785 Bupropion
math disorder, 795 smoking cessation in schizophrenics, 53
reading disorder, 795
Auditory cortex C-1073
tonotopy alterations of, in schizophrenia, 32 psychotic major depression treated using, 386
Autism Calbindin, 708
glutamic acid decarboxylase 65 and 67 kDA protein Calcium
reductions in, 805 serotonin 2A receptor-mediated mobilization of
serotonin and cerebral pathology in, 143—corr in cancer patients with depression, 1159
Aversive conditioning Calcium-binding proteins
social phobia and, 328 GABAergic neuron deficits in schizophrenia detected by,
708
Basal ganglia Calretinin, 708
blood flow Catecholamines
neuroleptic medications effect on, 855 parental care deprivation effects on, 1037
caudate of, 68 Catechol-O-methyltransferase Val,;,.Met polymorphism, 701
idiopathic focal dystonia, 356 Cerebellum. See also Brain
velo-cardio-facial syndrome and, 68 glutamic acid decarboxylase 65 and 67 KDA protein
Basic fibroblast growth factors reductions
anoxia effects on immunoreactivity of, 362 in autism patients, 805
Behavioral extinction, relapse after, 976 Cerebrospinal fluid
Bipolar disorder 5-HIAA levels
abuse and, 843—corr suicide attempts and, 375—corr
development of, 529 Cerebrovascular accident. See Stroke
dopamine D1 receptor gene and, 1144 Cerebrum. See also Brain
gray matter abnormalities in, 93 autism and, 143—corr
natural history of, 529 glucose utilization, in unipolar depression, 1031-—corr
physical abuse and, 843-—corr regional blood flow
research of, 503 panic disorder-related differences in, 126
sexual abuse and, 843—corr social phobia effects on, 1113
susceptibility loci for, 40 Children
treatment of attention-deficit/hyperactivity disorder in, 785, 795
novel types of, 589 dyslexia, neural system disruptions in, 101
psychosocial interventions, 610 hypothalamic-pituitary-adrenal activity, 776
white matter abnormalities in, 93 major depression in
Borderline personality disorder dorsolateral prefrontal cortex abnormalities associated
childhood abuse and, 1102 with, 86
hypothalamic-pituitary-adrenal axis hyperresponsive in, maltreated, posttraumatic stress disorder secondary to, 1066
1102 math disorder, 795
Brain. See also Amygdala; Cerebellum; Cerebrum; Prefrontal posttraumatic stress disorder in, 1066
cortex reading disorder, 795
child maltreatment-related posttraumatic stress disorder stress in
effects, 1066 description of, 773—ed
diffuse optical imaging, 679-rev maternal stress effects on sensitization to, 776
monoamine oxidase inhibition development of Chromosome 6, 847
pathological aggression secondary to, 811 Chromosome 3q
morphometric studies of susceptibility loci on, for schizophrenia and bipolar
in female victims of intimate partner violence with and disorder, 40
without posttraumatic stress disorder, 1089 Cingulate cortex
motor cortical excitability morphologic differences in schizophrenic men, 15
in schizophrenia, 24 Clinical trials
ventral frontal cortex morphology CONSORT standards, 62